Erbumine

DB18019InvestigationalSmall molecule

Erbumine: Overview.

Chemical structure of Erbumine
Formula / weight
C24H26ClF2N5O2 · 489.95 g/mol (avg)
Also known as
1-((3-chloro-2-fluorophenyl)methyl)-4-((3-fluoro-6-((5-methyl-1h-pyrazol-3-yl)amino)-2-pyridinyl)methyl)-2-methyl-, (2r,4r)-,4-piperidinecarboxylic acid · 4-piperidinecarboxylic acid, 1-((3-chloro-2-fluorophenyl)methyl)-4-((3-fluoro-6-((5-methyl-1h-pyrazol-3-yl)amino)-2-pyridinyl)methyl)-2-methyl-, (2r,4r)- · Aurora a kinase inhibitor ly3295668
Code names
AK-01 · LY-3295668

Resolves to

Compound
UNII1WX8O5XV4RCAS1919888-06-4
Structure
InChIKeyYQQZZYYQTCPEAS-OYLFLEFRSA-NSMILESC[C@@H]1C[C@@](CC2=NC(NC3=NNC(C)=C3)=CC=C2F)(CCN1CC1=CC=CC(Cl)=C1F)C(O)=O
Targets
O14965AURKA

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Erbumine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In